-
ABOUT USAffiliated to SSY Group Limited, Hebei Guangxiang Technology Co., Ltd., is a high-tech enterprise specializing in drug research and technology development.
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the synergy between “industry, academia, research and application” based on multi-disciplinary integration and multi-directional combination.
-
SUBORDINATEThe group has decided to establish research institutes in its subsidiaries, Hebei Ghuangxiang Drug Research Institute, Jiangsu Best Medical Material Research Institute, and Hebei Hanlin Biological Research Institute.
-
RECRUITWe actively establish a joint talent cultivation mechanism between schools and enterprises, and currently have over 500 high-level talents in various fields such as drug research, analysis, and clinical practice.
-
CONTACTWe will continue to strengthen innovation-driven development, vigorously promote the integration of production and research, constantly improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs.
Shi Si Yao Honored as One of China’s Top 100 Pharmaceutical Companies in 2019
Category:
Time：2020-08-26
Shi Si Pharmaceutical Named Among China’s Top 100 Chemical Pharmaceutical Companies in 2019
Ainoda Abidor Hydrochloride Capsules Honored as China’s Most Promising Pharmaceutical Brand.
The dazzling realm of the Ancient Tea-Horse Road—Wanxiu, where the quintessence of five colors converges. On the evening of August 25, under the brilliant starry sky of Kunming’s golden autumn, the annual grand event for the pharmaceutical industry was held as scheduled at the Yun’an Convention Center Hotel. Elite professionals from across the country gathered here to jointly witness the spectacular launch ceremony of the “2019 Top 100 Chinese Pharmaceutical Industry List.” Shisi Pharmaceutical made it onto the 2019 Top 100 Chinese Chemical Pharmaceutical Enterprises list, ranking 45th. Meanwhile, the company’s Aynoda Abidol Hydrochloride Capsules were honored as one of China’s Most Promising Pharmaceutical Brands.
As “leaders” in China’s pharmaceutical industry, the companies featured on this list have been selected by the Expert Committee of the Top 100 Chinese Pharmaceutical Enterprises Ranking. The ranking focuses on two key aspects: enterprises’ innovation-driven forces and their professional promotion capabilities. The innovation-driven force is primarily assessed based on comprehensive R&D investment indicators, while the professional promotion capability is rigorously defined according to quantitative terminal data reflecting the actual choices made by clinicians and patients. Leveraging the three major terminal and six market terminal database—developed and maintained by Minenet for many years—this ranking provides a scientific and rigorous evaluation of pharmaceutical enterprises.
In response to the international trend of increasing standardization and systematization in China’s pharmaceutical industry, the “2019 Top 100 Chinese Pharmaceutical Industry Rankings” has been subdivided into five sub-rankings: “Top 100 Chinese Chemical Pharmaceutical Companies,” “Top 100 Chinese Traditional Chinese Medicine Companies,” “Top 20 Chinese CRO (including CDMO) Companies,” “Top 20 Chinese Medical Device (including IVD) Companies,” and “Top 20 Chinese Biopharmaceutical Companies (including blood products, vaccines, insulin, etc.),” comprehensively showcasing the innovation dimensions across the entire industrial chain.
As a major backbone enterprise in China’s pharmaceutical industry, Shisi Pharmaceutical has put the new development philosophy into practice through its corporate strategic initiatives. It continues to deepen supply-side reform, optimize its production and sales structure, and foster synergistic development between its finished dosage forms and active pharmaceutical ingredient (API) segments. The proportion of new products keeps rising, enabling the company to advance rapidly on the path toward innovation, green development, and high-quality growth, thereby attracting widespread attention from both the industry and society.
The message delivered at the press conference to the top 100 pharmaceutical companies was both inspiring and thought-provoking: Faced with numerous challenges and difficulties, these companies have stood the test of time and reaped their well-deserved glory! There’s a pursuit called “never giving up”; there’s a contribution called “standing out from the crowd”; and there’s a success that truly lives up to its name. They’ve left a brilliant mark on the development journey of the pharmaceutical industry. Never slackening, always racing against time, they’ve become pioneers and leaders in the pharmaceutical sector.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Mobile site
E code